Published TCIMAIL newest issue No.197 | New tool "TCI SpectraViewer" | [TCIPracticalExample] The Synthesis of Rubicene... | Product Document Searching Made Easy by 2D Code!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 66357-59-3 | Product Number: R0073
Ranitidine Hydrochloride
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- N-[2-[5-[(Dimethylamino)methyl]furfurylthio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine Hydrochloride
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 5G |
₹4,500.00
|
2 | ≥100 |
|
| 25G |
₹7,600.00
|
1 | ≥60 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | R0073 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__3H__2__2N__4O__3S·HCl = 350.86 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| CAS RN | 66357-59-3 |
| Related CAS RN | 71130-06-8 |
| Reaxys Registry Number | 4342707 |
| PubChem Substance ID | 87575630 |
| Merck Index (14) | 8110 |
| MDL Number | MFCD00069339 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
Properties (reference)
| Melting Point | 135 °C(dec.) |
GHS
Related Laws:
| RTECS# | KM6557000 |
Transport Information:
Application
Ranitidine Hydrochloride: A Histamine H2-Receptor Antagonist
Ranitidine [R0261] and its hydrochloride are histamine H2-receptor antagonists. They have been reported as a potent inhibitors of gastric acid secretion effective in the treatment and prophylaxis of gastrointestinal lesions aggravated by gastric acid secretion. (The product is for research purpose only.)
References
- Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases
- Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases
- Ranitidine (a review on synthesis, physical properties, stability, methods of analysis and pharmacokinetics of ranitidine)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.